89
Participants
Start Date
October 8, 2013
Primary Completion Date
May 22, 2018
Study Completion Date
May 22, 2018
administration of stable isotope-labelled leucine-
\- administration of stable isotope-labelled leucine : by drip, for group 2A and group 2B. Group 1 (control group) : 1 collection of CSF. Group 2B : 4 collections of CSF, 24 hours after administration of stable isotope-labelled leucin. Group 2A (patients with brain trauma, acute hydrocephaly) : continuous collection of CSF, for 24 to 36 hours
collection of CSF, blood, urine, saliva
\- administration of stable isotope-labelled leucine : by drip, for group 2A and group 2B. Group 1 (control group) : 1 collection of CSF. Group 2B : 4 collections of CSF, 24 hours after administration of stable isotope-labelled leucin. Group 2A (patients with brain trauma, acute hydrocephaly) : continuous collection of CSF, for 24 to 36 hours
Laboratoire de Biochimie et Protéomique Clinique, CHU Montpellier, Montpellier
Collaborators (1)
Assistance Publique - Hôpitaux de Paris
OTHER
University Hospital, Clermont-Ferrand
OTHER
International Atomic Energy Agency
OTHER_GOV
University Hospital, Montpellier
OTHER